CA-MARY-KAY
24.2.2021 14:36:06 CET | Business Wire | Press release
Glamhive announced its fourth online conference to be held on February 27, 2021. The Glamhive Digital Winter Style and Beauty Summit will bring together top fashion and beauty leaders, from Kristen Bell's stylist to billion-dollar founder-turned female founder investor Cindy Eckert. The innovative leaders will discuss fashion, beauty, entrepreneurship, and more. Stephanie Sprangers and Nicole Chavez will co-host the event.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005275/en/
"I have loved being part of Glamhive's style & beauty summits, particularly during this challenging time. The summits have brought a sense of community, which is lacking in the world of creative talent, plus I have made some amazing connections with other artists along the way," said Nicole Chavez, celebrity stylist. Nicole is one of the most in-demand stylists today. Her clientele has ranged from A-List stars Kristen Bell, Rachel Bilson, Jessica Simpson, Ellie Bamber, Scarlett Johansson, Catherine Zeta-Jones, and many more. Her work has been featured in many publications, including W, InStyle, and Harper's Bazaar.
"Glamhive's vision is to give the benefits of working with a personal stylist available to everyone, everywhere, and our digital events are a wonderful extension of that. The silver lining of the past year is that it enabled us to pivot our style summits to digital, thereby making it possible for everyone, everywhere to meet and learn from the best in the business," said Stephanie Sprangers, Glamhive Founder and CEO. Sprangers is the Founder and Chief Executive Officer of Glamhive, the online personal styling service that brings expert personal stylists and makeup artists—recruited directly from Hollywood and Instagram—to everyone. Glamhive has developed proprietary software that allows stylists to take clients through a styling experience that is 100% online, allowing people to work with stylists anywhere in the world.
The all-day, ticketed event will feature over 60 speakers. Below is an overview of some of the topics that this all-star speaker line-up will cover.
TOPICS SNAPSHOT:
The day will consist of 22 segments across two-tracks. A snapshot:
- Red Carpet Style: Creating Iconic Style Moments
- 2021 Trends: Post-Pandemic Style
- Winning the Style Game: Vintage is Your Secret Weapon
- The Stylists Playbook: How to Get the Best Style of Your Life
- Beauty Boss Babe: An Interview with Jamie Kern Lima
- The Ultimate Guide to "Easy" Hair
- Let's Get Social: The Best Instagram and TikTok Beauty Trends
- The Astrology of Fashion: With Susan Miller
- More Than Meets the Eye: What Your Clothes Say About You
- The ROI of Style: How Dressing Well Pays Off
- How I Built This: Darn Good Advice from Women Who Made It to the Top
SPEAKERS:
Speakers include celebrity stylists, makeup artists, image-makers who work with the biggest names in Hollywood and beyond, including:
Angelina Jolie, Serena Williams, Mandy Moore, Sarah Jessica Parker, Kristen Bell, Khloe Kardashian, Robert Downey Jr., Keanu Reeves, Sharon Stone, Serena Williams, Miranda Lambert, Julianne Moore, and more.
CELEBRITY STYLISTS:
Nicole Chavez, Jill + Jordan, Jeanne Yang, Jennifer Rade, Tara Swennen, Janelle Miller, Lindsey Dupuis, Tiffany Gifford, Kesha McLoud, and Sonia Young.
CELEBRITY MAKEUP ARTISTS + HAIRSTYLISTS:
Tommy Buckett, Todd Harris, Diana Madison, Danny Moon, AJ Crimson, and Helen Reavey.
ENTREPRENEURS, DESIGNERS, AND BUSINESS LEADERS:
Claire Sulmers (Fashion Bomb Daily), Hillary Kerr (WhoWhatWear), Tara Rudes Dann (L'Agence), Steven Dann (Designer), Cindy Eckert (The Pink Ceiling Fund), Helen Ravey (Act+Acre), Cassandra Cadwell (Violet Grey), Michelle Waugh (Designer), Clarissa Egana (Port De Bras), Amy Rosoff Davis (Celebrity Trainer), Jamie Kern Lima (IT Cosmetics).
MODERATORS:
Brian Underwood (O Magazine), Brooke Jaffe (Penske Media), Pandora Amoratis (Daily Mail), Andrea Lavanthal (PEOPLE), Robin Nazzaro (O Magazine), Alexis Bennett (Vogue) and Kibwe Chase-Marshall (The Kelly Initiative).
Tickets to the conference are $149 for an all-day ticket. The Glamhive Digital Winter Style and Beauty Summit's presenting sponsor is Mary Kay Inc. and its Mary Kay Global Design Studio.
For more information, visit www.glamhive.com/upcoming .
About Glamhive
Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous.
The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. The Glamhive platform is a seamless end-to-end platform for stylists to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 57 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
